Figure 3. LncRNA HCP5 promotes the growth and migration of HCC in vivo. (A) Tumor growth curve suggesting that the knockdown of HCP5 results in lower tumor growth in vivo (**p<0.01, ***p<0.001). (B) Results of hematoxylin and eosin (HE) staining. (C) Immunohistochemistry demonstrating the expression of E-cadherin and vimentin between tissues transfected with sh-control and sh-HCP5. (D) Immunohistochemistry illustrating that the knockdown of HCP5 results in lower a proliferation rate in HCC tissue when compared to the control group.